Financials

News Ideas Discussions Technicals Forecast Seasonals

AVTX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Avalo Therapeutics, Inc.

Total assets of AVTX for Q1 25 is 138.52 M USD, 8.10% less than the previous Q4 24. And total liabilities decreased by 10.12% in Q1 25 to 15.91 M USD.

Q1 '17

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD